Array
(
[id] => 6591119
[patent_doc_number] => 20100130500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY HYPERTENSION OF THE NEWBORN'
[patent_app_type] => utility
[patent_app_number] => 11/720815
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23054
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130500.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720815
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720815 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY HYPERTENSION OF THE NEWBORN | Dec 7, 2005 | Abandoned |
Array
(
[id] => 5480824
[patent_doc_number] => 20090203781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'N-N-Acyloxypropyl Lysine Methyl Ester-and N,N-Bis(N-Acyloxypropyl) Lysine Methyl Ester-Type Compounds and Use Thereof as Surface-Active Agents with an Antimicrobial Activity'
[patent_app_type] => utility
[patent_app_number] => 11/667918
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2430
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667918
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667918 | N-N-Acyloxypropyl Lysine Methyl Ester-and N,N-Bis(N-Acyloxypropyl) Lysine Methyl Ester-Type Compounds and Use Thereof as Surface-Active Agents with an Antimicrobial Activity | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5316492
[patent_doc_number] => 20090281090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'BIOMARKERS FOR THE PREDICTION OF RESPONSIVENESS TO CLOZAPINE TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/571001
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24395
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571001 | BIOMARKERS FOR THE PREDICTION OF RESPONSIVENESS TO CLOZAPINE TREATMENT | Jun 2, 2005 | Abandoned |
Array
(
[id] => 6007948
[patent_doc_number] => 20110059979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators'
[patent_app_type] => utility
[patent_app_number] => 10/568028
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4462
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568028 | Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators | Aug 11, 2004 | Abandoned |
Array
(
[id] => 6944330
[patent_doc_number] => 20050196379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Combination therapies with L-FMAU for the treatment of hepatitis B virus infection'
[patent_app_type] => utility
[patent_app_number] => 10/618531
[patent_app_country] => US
[patent_app_date] => 2003-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19815
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196379.pdf
[firstpage_image] =>[orig_patent_app_number] => 10618531
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/618531 | Combination therapies with L-FMAU for the treatment of hepatitis B virus infection | Jul 10, 2003 | Abandoned |